XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Assets:    
Cash and due from banks $ 100,693 $ 85,409
Cash at Federal Reserve and other banks 198,127 59,547
Cash and cash equivalents 298,820 144,956
Investment securities:    
Marketable equity securities 2,681 2,609
Available for sale debt securities, at fair value (amortized cost of $1,906,961 and $2,138,533) 1,740,756 1,904,885
Held to maturity debt securities, at amortized cost, net of allowance for credit losses of $0 95,446 111,866
Restricted equity securities 17,250 17,250
Loans held for sale 2,785 709
Loans 7,006,824 6,768,523
Allowance for credit losses (124,571) (125,366)
Total loans, net 6,882,253 6,643,157
Premises and equipment, net 70,509 70,287
Cash value of life insurance 136,391 140,149
Accrued interest receivable 32,126 34,810
Goodwill 304,442 304,442
Other intangible assets, net 4,953 6,432
Operating leases, right-of-use 25,917 23,529
Other assets 264,507 268,647
Total assets 9,878,836 9,673,728
Deposits:    
Noninterest-bearing demand 2,544,306 2,548,613
Interest-bearing 5,790,155 5,538,963
Total deposits 8,334,461 8,087,576
Accrued interest payable 8,241 11,501
Operating lease liability 27,683 25,437
Other liabilities 145,869 137,506
Other borrowings 17,039 89,610
Junior subordinated debt 41,238 101,191
Total liabilities 8,574,531 8,452,821
Commitments and contingencies (Note 9)
Shareholders’ equity:    
Preferred stock, no par value: 1,000,000 shares authorized, zero issued and outstanding at September 30, 2025 and December 31, 2024 0 0
Common stock, no par value: 50,000,000 shares authorized; 32,506,880 and 32,970,425 issued and outstanding at September 30, 2025 and December 31, 2024, respectively 685,594 693,462
Retained earnings 723,668 679,907
Accumulated other comprehensive loss, net of tax (104,957) (152,462)
Total shareholders’ equity 1,304,305 1,220,907
Total liabilities and shareholders’ equity $ 9,878,836 $ 9,673,728